As the assays of invasion and migration were performed prior to observation of apoptosis, we suggest that Tβ10 overexpression in ovarian cancer may have beneficial cell-killing effects of primary tumor cells as well as metastatic cells. Here, TMSB10 is linked to ovarian carcinoma.